Search Results 11-20 of 17439 for Temporal+arteritis
About this study. The purpose of this study is to determine the effectiveness of abatacept in Giant Cell Arteritis (GCA). Patients who have newly diagnosed ...
This study will evaluate the safety and effectiveness of baricitinib in the treatment of giant cell arteritis. All participants will be taking prednisone at ...
Age. Giant cell arteritis is rare before the age of 50. · Family history. Behcets disease, granulomatosis with polyangiitis and Kawasaki disease can run in ...
Relapse Prediction Following Discontinuation of Tocilizumab In Giant Cell Arteritis · Overview · Participation eligibility · Participating Mayo Clinic locations.
... giant cell arteritis and Takayasu arteritis. Arthritis & Rheumatology. 2021; doi:10.1002/art.41774. AskMayoExpert. Takayasu arteritis. Mayo Clinic; 2024 ...
... Giant cell arteritis, Takayasu's arteritis, Brain hemorrhage, Spinal arteriovenous malformation, Dural arteriovenous fistula, Intracranial venous ...
Head pain and tenderness are the most common symptoms of giant cell arteritis, an inflammation of the lining of your arteries.
... temporal arteries with giant cell arteritis (GCA), determine if their serum levels could be useful for diagnosis and/or follow up of patients with GCA, and ...
Blurred or double vision or vision loss. Tender scalp. To confirm a diagnosis of giant cell arteritis, you may have an ultrasound or a biopsy of an artery in ...
A Study Testing the Effectiveness and Safety of KPL-301 in Patients with Giant Cell Arteritis · Overview · Participation eligibility · Participating Mayo Clinic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.